Citigroup »

Iovance Biotherapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.1M 754k 8.13
2023-09-30 $4.5M 987k 4.55
2023-03-31 $8.8M 1.4M 6.11
2022-12-31 $3.3M 519k 6.39
2022-09-30 $4.2M 570k 7.30
2021-12-31 $4.6M 242k 19.17
2021-03-31 $5.2M 165k 31.65
2020-12-31 $2.2M 48k 46.41
2020-09-30 $1.3M 41k 32.91
2020-06-30 $7.7M 281k 27.44
2020-03-31 $3.6M 121k 29.93
2019-12-31 $1.9M 69k 27.68
2019-09-30 $3.0M 164k 18.20
2019-06-30 $2.9M 117k 24.52
2019-03-31 $379k 40k 9.52
2018-12-31 $2.2M 244k 8.84
2018-09-30 $289k 26k 11.22
2018-06-30 $244k 19k 12.83
2018-03-31 $307k 18k 16.92
2017-12-31 $467k 58k 8.00
2017-09-30 $33k 4.3k 7.73
2017-06-30 $6.3k 945 6.70